Hashibe Mia, Herget Kimberly A, Schiffman Joshua D, Chang Vivian Y
Department of Family and Preventive Medicine, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
Int J Cancer. 2025 Apr 15;156(8):1563-1571. doi: 10.1002/ijc.35259. Epub 2024 Nov 27.
While some previous studies disaggregated the Asian, Native Hawaiian, and Pacific Islander (ANHPI) population to investigate survival for childhood leukemia, further studies are needed to understand the differences between subpopulations. The aim of our study was to estimate 5-year relative survival for patients with childhood leukemia and to investigate disparities in prognostic factors with disaggregation of the ANHPI population. We used the Surveillance, Epidemiology, and End Results Program 17 database and included 1881 ANHPI patients with childhood leukemia and 8772 non-Hispanic White (NHW) patients with childhood leukemia. The Cox proportional hazards model was used to estimate hazard ratios for the risk of death. We observed lower 5-year relative survival rates for Southeast Asian and East Asian compared to NHW patients with childhood leukemia for acute lymphoid leukemia (ALL). The survival rates were higher for patients diagnosed at 1-9 years of age, more recent years of diagnosis, and patients residing in urban areas. The risk of death was 42% higher for East Asian patients and 50% higher for Southeast Asian patients compared to NHW patients for childhood ALL. For prognostic factors among East Asian patients with childhood leukemia, higher risks of death were observed for patients diagnosed at <12 months old and for acute myeloid leukemia compared to ALL. Further studies are needed to elucidate the reasons behind the disparities in survival rates for Southeast Asian and East Asian patients with childhood leukemia, including socioeconomic and genetic contributions to leukemia risk and clinical responses to different therapeutic modalities.
虽然之前的一些研究对亚洲、夏威夷原住民和太平洋岛民(ANHPI)人群进行了细分,以调查儿童白血病的生存率,但仍需要进一步的研究来了解亚人群之间的差异。我们研究的目的是估计儿童白血病患者的5年相对生存率,并在对ANHPI人群进行细分的情况下调查预后因素的差异。我们使用了监测、流行病学和最终结果计划17数据库,纳入了1881名患有儿童白血病的ANHPI患者和8772名患有儿童白血病的非西班牙裔白人(NHW)患者。采用Cox比例风险模型来估计死亡风险的风险比。我们观察到,与患有急性淋巴细胞白血病(ALL)的NHW儿童白血病患者相比,东南亚和东亚患者的5年相对生存率较低。1-9岁诊断的患者、近年诊断的患者以及居住在城市地区的患者生存率较高。与NHW儿童ALL患者相比,东亚患者的死亡风险高42%,东南亚患者高50%。对于患有儿童白血病的东亚患者的预后因素,与ALL相比,<12个月大诊断的患者和急性髓细胞白血病患者的死亡风险更高。需要进一步的研究来阐明东南亚和东亚儿童白血病患者生存率差异背后的原因,包括社会经济和遗传因素对白血病风险的影响以及对不同治疗方式的临床反应。